PhaseBio Pharmaceuticals Inc
PhaseBio Pharmaceuticals Inc (PHAS) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 113 transactions totaling $15.6M, demonstrating a bullish sentiment with $14.9M in net insider flow. The most recent transaction on May 19, 2023 involved a transaction of 3,750 shares valued at $0.
PHAS Insider Activity Summary
Who Is Buying PHAS Stock?
No significant insider buying has been recorded for PHAS in the recent period.
Who Is Selling PHAS Stock?
No significant insider selling has been recorded for PHAS in the recent period.
Is PhaseBio Pharmaceuticals Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PHAS is bullish with an Insider Alignment Score of 98/100 and a net flow of $14.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PHAS Frequently Asked Questions
Understanding PHAS Insider Activity
Insider trading at PhaseBio Pharmaceuticals Inc (PHAS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading PHAS stock, having executed 113 transactions in the past 90 days. The most active insider is Scott D. Sandell (Executive), who has made 2 transactions totaling $9.0M.
Related Tools
Track PhaseBio Pharmaceuticals Inc Insider Activity
Get notified when executives and directors at PHAS file new Form 4 transactions